Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in Crohn's Disease (CD)

NCT01105741 · clinicaltrials.gov ↗
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Martin Storr

Collaborators